Bellus: Q3 Earnings Snapshot

LAVAL, Quebec (AP) _ Bellus Health Inc. (BLU) on Monday reported a loss of $24.7 million in its third quarter.

The Laval, Quebec-based company said it had a loss of 20 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The drug developer posted revenue of $4,000 in the period.

Bellus shares have climbed 14% since the beginning of the year. In the final minutes of trading on Monday, shares hit $9.15, an increase of 30% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a BLU">Zacks stock report on BLU at https://www.zacks.com/ap/BLU